ANTIEPILEPTIC, HYPOCHOLESTEROLEMIC AND NEUROPROTECTIVE COMPOUND

The invention relates to a compound having formula (I), the hydroxyacid form thereof, the pharmaceutically acceptable salts of the hydroxyacid and prodrugs and pharmaceutically acceptable solvates of the compound and the hydroxyacid form thereof and, in particular, the compound and the hydroxyacid f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SALETA SIERRA AVILA, JAVIER VELASCO ALVAREZ, JOSE LUIS ADRIO FONDEVILA, SONIA CAMPOY GARCIA, JAVIER SANTOS BURGOS MUNOZ, JUAN MARIA ALFARO SANCHEZ, ANGEL RUMBERO SANCHEZ, MARIA DEL CARMEN RAMOS MARTIN, CARLOS RAMIREZ MORENO
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SALETA SIERRA AVILA
JAVIER VELASCO ALVAREZ
JOSE LUIS ADRIO FONDEVILA
SONIA CAMPOY GARCIA
JAVIER SANTOS BURGOS MUNOZ
JUAN MARIA ALFARO SANCHEZ
ANGEL RUMBERO SANCHEZ
MARIA DEL CARMEN RAMOS MARTIN
CARLOS RAMIREZ MORENO
description The invention relates to a compound having formula (I), the hydroxyacid form thereof, the pharmaceutically acceptable salts of the hydroxyacid and prodrugs and pharmaceutically acceptable solvates of the compound and the hydroxyacid form thereof and, in particular, the compound and the hydroxyacid form and salts thereof, etc. for use in the prevention of: neurodegenerative diseases, cognitive deterioration, diseases associated with unwanted oxidation, pathological processes associated with age and progeria, epilepsy, epileptic seizures and convulsions, cardiovascular diseases, such as atherosclerosis, auricular fibrillation, dyslipemia, hypercholesterolaemia, hyperlipidaemia and hypertriglyceridemia or fungal or viral infections. Se describe un compuesto de fórmula (I) (ver fórmula (I)) su forma hidroxiácida, las sales farmacéuticamente aceptables de dicho hidroxiácido y prodrogas y solvatos farmacéuticamente aceptables del compuesto y de su forma hidroxiácida y, en particular, dicho compuesto, su forma hidroxiácida, sales, etc. para su uso en la prevención de: enfermedades neurodegenerativas, deterioro cognitivo, enfermedades asociadas con una oxidación indeseada, procesos patológicos asociados a la edad y progeria, epilepsia, crisis epilépticas y convulsiones, enfermedades cardiovasculares como aterosclerosis, fibrilación auricular, dislipemia, hipercolesterolemia, hiperlipidemia, e hipertrigliceridemia, o infecciones fúngicas o viricas.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2011010978A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2011010978A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2011010978A3</originalsourceid><addsrcrecordid>eNrjZLB39AvxdA3w9HENCPF01lHwiAzwd_bw93ENDnENAlK-ns4Kjn4uCn6uoUH-AUH-Ia7OIZ5hrgrO_r4B_qF-LjwMrGmJOcWpvFCam0HJzTXE2UM3tSA_PrW4IDE5NS-1JN43wsjA0NDA0MDS3MLRmChFACSaK4k</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTIEPILEPTIC, HYPOCHOLESTEROLEMIC AND NEUROPROTECTIVE COMPOUND</title><source>esp@cenet</source><creator>SALETA SIERRA AVILA ; JAVIER VELASCO ALVAREZ ; JOSE LUIS ADRIO FONDEVILA ; SONIA CAMPOY GARCIA ; JAVIER SANTOS BURGOS MUNOZ ; JUAN MARIA ALFARO SANCHEZ ; ANGEL RUMBERO SANCHEZ ; MARIA DEL CARMEN RAMOS MARTIN ; CARLOS RAMIREZ MORENO</creator><creatorcontrib>SALETA SIERRA AVILA ; JAVIER VELASCO ALVAREZ ; JOSE LUIS ADRIO FONDEVILA ; SONIA CAMPOY GARCIA ; JAVIER SANTOS BURGOS MUNOZ ; JUAN MARIA ALFARO SANCHEZ ; ANGEL RUMBERO SANCHEZ ; MARIA DEL CARMEN RAMOS MARTIN ; CARLOS RAMIREZ MORENO</creatorcontrib><description>The invention relates to a compound having formula (I), the hydroxyacid form thereof, the pharmaceutically acceptable salts of the hydroxyacid and prodrugs and pharmaceutically acceptable solvates of the compound and the hydroxyacid form thereof and, in particular, the compound and the hydroxyacid form and salts thereof, etc. for use in the prevention of: neurodegenerative diseases, cognitive deterioration, diseases associated with unwanted oxidation, pathological processes associated with age and progeria, epilepsy, epileptic seizures and convulsions, cardiovascular diseases, such as atherosclerosis, auricular fibrillation, dyslipemia, hypercholesterolaemia, hyperlipidaemia and hypertriglyceridemia or fungal or viral infections. Se describe un compuesto de fórmula (I) (ver fórmula (I)) su forma hidroxiácida, las sales farmacéuticamente aceptables de dicho hidroxiácido y prodrogas y solvatos farmacéuticamente aceptables del compuesto y de su forma hidroxiácida y, en particular, dicho compuesto, su forma hidroxiácida, sales, etc. para su uso en la prevención de: enfermedades neurodegenerativas, deterioro cognitivo, enfermedades asociadas con una oxidación indeseada, procesos patológicos asociados a la edad y progeria, epilepsia, crisis epilépticas y convulsiones, enfermedades cardiovasculares como aterosclerosis, fibrilación auricular, dislipemia, hipercolesterolemia, hiperlipidemia, e hipertrigliceridemia, o infecciones fúngicas o viricas.</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120119&amp;DB=EPODOC&amp;CC=MX&amp;NR=2011010978A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120119&amp;DB=EPODOC&amp;CC=MX&amp;NR=2011010978A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SALETA SIERRA AVILA</creatorcontrib><creatorcontrib>JAVIER VELASCO ALVAREZ</creatorcontrib><creatorcontrib>JOSE LUIS ADRIO FONDEVILA</creatorcontrib><creatorcontrib>SONIA CAMPOY GARCIA</creatorcontrib><creatorcontrib>JAVIER SANTOS BURGOS MUNOZ</creatorcontrib><creatorcontrib>JUAN MARIA ALFARO SANCHEZ</creatorcontrib><creatorcontrib>ANGEL RUMBERO SANCHEZ</creatorcontrib><creatorcontrib>MARIA DEL CARMEN RAMOS MARTIN</creatorcontrib><creatorcontrib>CARLOS RAMIREZ MORENO</creatorcontrib><title>ANTIEPILEPTIC, HYPOCHOLESTEROLEMIC AND NEUROPROTECTIVE COMPOUND</title><description>The invention relates to a compound having formula (I), the hydroxyacid form thereof, the pharmaceutically acceptable salts of the hydroxyacid and prodrugs and pharmaceutically acceptable solvates of the compound and the hydroxyacid form thereof and, in particular, the compound and the hydroxyacid form and salts thereof, etc. for use in the prevention of: neurodegenerative diseases, cognitive deterioration, diseases associated with unwanted oxidation, pathological processes associated with age and progeria, epilepsy, epileptic seizures and convulsions, cardiovascular diseases, such as atherosclerosis, auricular fibrillation, dyslipemia, hypercholesterolaemia, hyperlipidaemia and hypertriglyceridemia or fungal or viral infections. Se describe un compuesto de fórmula (I) (ver fórmula (I)) su forma hidroxiácida, las sales farmacéuticamente aceptables de dicho hidroxiácido y prodrogas y solvatos farmacéuticamente aceptables del compuesto y de su forma hidroxiácida y, en particular, dicho compuesto, su forma hidroxiácida, sales, etc. para su uso en la prevención de: enfermedades neurodegenerativas, deterioro cognitivo, enfermedades asociadas con una oxidación indeseada, procesos patológicos asociados a la edad y progeria, epilepsia, crisis epilépticas y convulsiones, enfermedades cardiovasculares como aterosclerosis, fibrilación auricular, dislipemia, hipercolesterolemia, hiperlipidemia, e hipertrigliceridemia, o infecciones fúngicas o viricas.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB39AvxdA3w9HENCPF01lHwiAzwd_bw93ENDnENAlK-ns4Kjn4uCn6uoUH-AUH-Ia7OIZ5hrgrO_r4B_qF-LjwMrGmJOcWpvFCam0HJzTXE2UM3tSA_PrW4IDE5NS-1JN43wsjA0NDA0MDS3MLRmChFACSaK4k</recordid><startdate>20120119</startdate><enddate>20120119</enddate><creator>SALETA SIERRA AVILA</creator><creator>JAVIER VELASCO ALVAREZ</creator><creator>JOSE LUIS ADRIO FONDEVILA</creator><creator>SONIA CAMPOY GARCIA</creator><creator>JAVIER SANTOS BURGOS MUNOZ</creator><creator>JUAN MARIA ALFARO SANCHEZ</creator><creator>ANGEL RUMBERO SANCHEZ</creator><creator>MARIA DEL CARMEN RAMOS MARTIN</creator><creator>CARLOS RAMIREZ MORENO</creator><scope>EVB</scope></search><sort><creationdate>20120119</creationdate><title>ANTIEPILEPTIC, HYPOCHOLESTEROLEMIC AND NEUROPROTECTIVE COMPOUND</title><author>SALETA SIERRA AVILA ; JAVIER VELASCO ALVAREZ ; JOSE LUIS ADRIO FONDEVILA ; SONIA CAMPOY GARCIA ; JAVIER SANTOS BURGOS MUNOZ ; JUAN MARIA ALFARO SANCHEZ ; ANGEL RUMBERO SANCHEZ ; MARIA DEL CARMEN RAMOS MARTIN ; CARLOS RAMIREZ MORENO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2011010978A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SALETA SIERRA AVILA</creatorcontrib><creatorcontrib>JAVIER VELASCO ALVAREZ</creatorcontrib><creatorcontrib>JOSE LUIS ADRIO FONDEVILA</creatorcontrib><creatorcontrib>SONIA CAMPOY GARCIA</creatorcontrib><creatorcontrib>JAVIER SANTOS BURGOS MUNOZ</creatorcontrib><creatorcontrib>JUAN MARIA ALFARO SANCHEZ</creatorcontrib><creatorcontrib>ANGEL RUMBERO SANCHEZ</creatorcontrib><creatorcontrib>MARIA DEL CARMEN RAMOS MARTIN</creatorcontrib><creatorcontrib>CARLOS RAMIREZ MORENO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SALETA SIERRA AVILA</au><au>JAVIER VELASCO ALVAREZ</au><au>JOSE LUIS ADRIO FONDEVILA</au><au>SONIA CAMPOY GARCIA</au><au>JAVIER SANTOS BURGOS MUNOZ</au><au>JUAN MARIA ALFARO SANCHEZ</au><au>ANGEL RUMBERO SANCHEZ</au><au>MARIA DEL CARMEN RAMOS MARTIN</au><au>CARLOS RAMIREZ MORENO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTIEPILEPTIC, HYPOCHOLESTEROLEMIC AND NEUROPROTECTIVE COMPOUND</title><date>2012-01-19</date><risdate>2012</risdate><abstract>The invention relates to a compound having formula (I), the hydroxyacid form thereof, the pharmaceutically acceptable salts of the hydroxyacid and prodrugs and pharmaceutically acceptable solvates of the compound and the hydroxyacid form thereof and, in particular, the compound and the hydroxyacid form and salts thereof, etc. for use in the prevention of: neurodegenerative diseases, cognitive deterioration, diseases associated with unwanted oxidation, pathological processes associated with age and progeria, epilepsy, epileptic seizures and convulsions, cardiovascular diseases, such as atherosclerosis, auricular fibrillation, dyslipemia, hypercholesterolaemia, hyperlipidaemia and hypertriglyceridemia or fungal or viral infections. Se describe un compuesto de fórmula (I) (ver fórmula (I)) su forma hidroxiácida, las sales farmacéuticamente aceptables de dicho hidroxiácido y prodrogas y solvatos farmacéuticamente aceptables del compuesto y de su forma hidroxiácida y, en particular, dicho compuesto, su forma hidroxiácida, sales, etc. para su uso en la prevención de: enfermedades neurodegenerativas, deterioro cognitivo, enfermedades asociadas con una oxidación indeseada, procesos patológicos asociados a la edad y progeria, epilepsia, crisis epilépticas y convulsiones, enfermedades cardiovasculares como aterosclerosis, fibrilación auricular, dislipemia, hipercolesterolemia, hiperlipidemia, e hipertrigliceridemia, o infecciones fúngicas o viricas.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX2011010978A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ANTIEPILEPTIC, HYPOCHOLESTEROLEMIC AND NEUROPROTECTIVE COMPOUND
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T05%3A13%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SALETA%20SIERRA%20AVILA&rft.date=2012-01-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2011010978A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true